OCX Annual Accounts Receivable
$484.00 K
-$1.53 M-75.94%
31 December 2023
Summary:
As of January 23, 2025, OCX annual accounts receivable is $484.00 thousand, with the most recent change of -$1.53 million (-75.94%) on December 31, 2023. During the last 3 years, it has risen by +$281.00 thousand (+138.42%). OCX annual accounts receivable is now -75.94% below its all-time high of $2.01 million, reached on December 31, 2022.OCX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCX Quarterly Accounts Receivable
$209.00 K
+$124.00 K+145.88%
30 September 2024
Summary:
As of January 23, 2025, OCX quarterly accounts receivable is $209.00 thousand, with the most recent change of +$124.00 thousand (+145.88%) on September 30, 2024. Over the past year, it has dropped by -$1.67 million (-88.89%). OCX quarterly accounts receivable is now -90.15% below its all-time high of $2.12 million, reached on March 31, 2022.OCX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.9% | -88.9% |
| 3 y3 years | +138.4% | -88.4% |
| 5 y5 years | - | -88.4% |
OCX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.9% | at low | -90.2% | +145.9% |
| 5 y | 5-year | -75.9% | -90.2% | ||
| alltime | all time | -75.9% | -90.2% |
OncoCyte Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $209.00 K(+145.9%) |
| June 2024 | - | $85.00 K(-47.2%) |
| Mar 2024 | - | $161.00 K(-66.7%) |
| Dec 2023 | $484.00 K(-75.9%) | $484.00 K(-74.3%) |
| Sept 2023 | - | $1.88 M(+9.7%) |
| June 2023 | - | $1.72 M(-9.7%) |
| Mar 2023 | - | $1.90 M(-5.5%) |
| Dec 2022 | $2.01 M | $2.01 M(+1.1%) |
| Sept 2022 | - | $1.99 M(+10.4%) |
| June 2022 | - | $1.80 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.12 M(+47.7%) |
| Dec 2021 | $1.44 M(+607.9%) | $1.44 M(+39.2%) |
| Sept 2021 | - | $1.03 M(+0.7%) |
| June 2021 | - | $1.02 M(+45.8%) |
| Mar 2021 | - | $703.00 K(+246.3%) |
| Dec 2020 | $203.00 K(>+9900.0%) | $203.00 K(-44.5%) |
| Sept 2020 | - | $366.00 K(+363.3%) |
| June 2020 | - | $79.00 K(+507.7%) |
| Mar 2020 | - | $13.00 K(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is OncoCyte annual accounts receivable?
- What is the all time high annual accounts receivable for OncoCyte?
- What is OncoCyte annual accounts receivable year-on-year change?
- What is OncoCyte quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for OncoCyte?
- What is OncoCyte quarterly accounts receivable year-on-year change?
What is OncoCyte annual accounts receivable?
The current annual accounts receivable of OCX is $484.00 K
What is the all time high annual accounts receivable for OncoCyte?
OncoCyte all-time high annual accounts receivable is $2.01 M
What is OncoCyte annual accounts receivable year-on-year change?
Over the past year, OCX annual accounts receivable has changed by -$1.53 M (-75.94%)
What is OncoCyte quarterly accounts receivable?
The current quarterly accounts receivable of OCX is $209.00 K
What is the all time high quarterly accounts receivable for OncoCyte?
OncoCyte all-time high quarterly accounts receivable is $2.12 M
What is OncoCyte quarterly accounts receivable year-on-year change?
Over the past year, OCX quarterly accounts receivable has changed by -$1.67 M (-88.89%)